The Pharmacology of Levodopa in Treatment of Parkinson’s Disease: An Update
- 1 January 1989
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Effect of l-DOPA on glucose oxidation and incorporation into glycogen in discrete brain regions of the ratBrain Research, 1985
- L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatumJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- ?On-off? phenomenon in Parkinson's disease: Correlation to the concentration of dopa in plasmaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Recent advances in the treatment of Parkinson's disease: The role of bromocriptineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976
- L-dopa level in plasma, primary condition for the kinetic effectJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1973
- On the mode of action of l-dopa in Parkinson's diseaseBiochemical Medicine, 1970
- Effect of amine precursors on the concentration of striatal dopamine and serotonin in cats with and without unilateral brain stem lesionsBrain Research, 1967
- Über das sympathicomimetische pressorische Prinzip des Harns („Urosympathin“)Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1947